Related Articles
FDA pulls Covid antibody treatment because it’s not effective against dominant omicron variants
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters A key monoclonal antibody used to treat people with weak immune systems who catch Covid is no longer authorized for use in the U.S. because it is not effective against […]
Cannabis by-products could interfere with medications
As cannabis use becomes more widely acceptable and gains legalization in Canada and U.S. states, concern surrounding potential interactions with common medications has surfaced. In previous studies, cannabis derivatives have been shown to inhibit P450 enzymes, but the extent of this interference has been unstudied. A new study from Washington State University is the first […]
China could reopen in March, but zero-Covid has shaken confidence in supply chains, economist says
While Chinese authorities could gradually unwind restrictions in March, zero-Covid policies are starting to hurt global confidence in the country’s industrial supply chains, said Li Daokui, Mansfield Freeman professor of economics at China’s Tsinghua University. In the short term, supply chains will be largely unaffected since factories are still operating even if consumption is lower […]